1 Vaverkova H, Karasek D, Novotny D, et al. Positiveassociation of adiponectin with soluble vascular celladhesion molecule sVCAM-1 levels in patients withvascular disease or dyslipidemia[J]. Atherosclerosis,2008, 197:725-731.2 Liao W, Yu C, Wen J, et al. Adiponectin inducesinterleukin-6 production and activates STAT3 in adultmouse cardiac fibroblasts[J]. Biol Cell, 2009, 101:263-272.3 Ouchi N, Walsh K. A novel role for adiponectin in theregulation of inflammation[J]. Arterioscler ThrombVasc Biol, 2008, 28:1219-1221.4 Zhang R, Yin X, Shi H, et al. Adiponectin modulatesDCA-induced inflammation via the ROS/NF-kappaB signaling pathway in esophageal adenocarcinomacells[J]. Dig Dis Sci, 2014, 59:89-97.5 Efstathiou SP, Tsioulos DI, Tsiakou AG, et al. Plasmaadiponectin levels and five-year survival after firsteverischemic stroke[J]. Stroke, 2005, 36:1915-1919.6 Bienek R, Marek B, Kajdaniuk D, et al. Adiponectin,leptin, resistin and insulin blood concentrations inpatients with ischaemic cerebral stroke[J]. EndokrynolPol, 2012, 63:338-345.7 Pera J, Dziedzic T, Szczudlik A, et al. Temporalchanges of adiponectin plasma levels in patients withacute ischemic stroke[J]. Neurol Res, 2013, 35:988-991.8 Chen B, Liao WQ, Xu N, et al. Adiponectin protectsagainst cerebral ischemia-reperfusion injury throughanti-inf lammatory action[J]. Brain Res, 2009,1273:129-137.9 Ni sh imu r a M, I z umiya Y, Hig uch i A, e t a l .Adiponectin prevents cerebral ischemic injurythrough endothelial nitric oxide synthase dependentmechanisms[J]. Circulation, 2008, 117:216-223.10 Maeda K, Okubo K, Shimomura I, et al. cDNAcloning and expression of a novel adipose specificcollagen-like factor, apM1 (AdiPose Most abundantGene transcript 1)[J]. Biochem Biophys Res Commun,1996, 221:286-289.11 Francke S, Manraj M, Lacquemant C, et al. A genomewidescan for coronary heart disease suggests in Indo-Mauritians asusceptibility locus on chromosome16p13 and replicates linkage with the metabolicsyndrome on 3q27[J]. Hum Mol Genet, 2001, 10:2751-2765.12 Li YY, Yang ZJ, Zhou CW, et al. Adiponectin-11377CG gene polymorphism and type 2 diabetesmellitus in the Chinese population:a meta-analysis of6425 subjects[J]. PLoS One, 2013, 8:e61153.13 Za dja l i F, Al -Ya hya e e S, Ha s s a n MO, e t a l .Association of adiponectin promoter var iantswith traits and clusters of metabolic syndrome inArabs:family-based study[J]. Gene, 2013, 527:663-669. 14 Kat akami N, Kaneto H, Mat suoka TA, et al.Adiponectin G276T gene polymorphism is associatedwith cardiovascular disease in Japanese patients withtype 2 diabetes[J]. Atherosclerosis, 2012, 220:437-442.15 中华神经科学会, 中华神经外科学会. 各类脑血管疾病诊断要点[J]. 中华神经科杂志, 1996, 29:379-380.16 周玉珍, 鲍俊, 王鹏. 健康与社会行为吸烟、饮酒和吸烟饮酒协同作用对脑血流动力学的影响[J]. 现代预防医学, 2012, 39:3025-3027.17 Liu F, He Z, Deng S, et al. Association of adiponectingene polymorphisms with the risk of ischemic strokein a Chinese Han population[J]. Mol Biol Rep, 2011,38:1983-1988.18 陈小良, 程锦泉, 张仁利, 等. 脂联素基因多态性与北方汉族人群缺血性脑卒中易感性关系研究[J]. 中华流行病学杂志, 20l0, 31:129-132.19 Patel S, Flyvbjerg A, Kozàkovà M, et al. Variationin the ADIPOQ gene promoter is associated withcarotid intima media thickness independent of plasmaadiponectin levels in healthy subjects[J]. Eur Heart J,2008, 29:386-393.20 Hegener HH, Lee IM, Cook NR, et al. Associationof adiponectin gene variations with risk of incidentmyocardial infarction and ischemic stroke:a nestedcase-control study[J]. Clin Chem, 2006, 52:2021-2027.21 Laumen H, Saningong AD, Heid IM, et al. Functionalcha r a ct e r i z at ion of promot e r va r iant s of theadiponectin gene complemented by epidemiologicaldata[J]. Diabetes, 2009, 58:984-991.22 Zhang D, Ma J, Brismar K, et al. A single nucleotidepolymorphism alters the sequence of SP1 binding sitein the adiponectin promoter region and is associatedwith diabetic nephropathy among type 1 diabeticpatients in the Genetics of Kidneys in Diabetes Study[J]. J Diabetes Complications, 2009, 23:265-272.23 Ferguson JF, Phillips CM, Tierney AC, et al. Genenutrientinteractions in the metabolic syndrome:singlenucleotide polymorphisms in ADIPOQ and ADIPOR1interact with plasma saturated fatty acids to modulateinsulin resistance[J]. Am J Clin Nutr, 2010, 91:794-801.24 Bang OY, Saver JL, Ovbiagele B, et al. Adiponectinlevels in patients with intracranial atherosclerosis[J].Neurology, 2007, 68:1931-1937.25 Ong KL, Li M, Tso AW, et al. Association of geneticvariants in the adiponectin gene with adiponectinlevel and hypertension in Hong Kong Chinese[J]. EurJ Endocrinol, 2010, 163:251-257.26 Ma c h a d o JS , Pa l e i AC, Ama r a l LM, e t a l .Polymorphisms of the adiponectin gene in gestationalhypertension and pre-eclampsia[J]. J Hum Hypertens,2014, 28:128-132.27 Yamada Y, Kato K, Oguri M, et al. Associationof genetic variants with atherothrombotic cerebralinfarction in Japanese individuals with metabolicsyndrome[J]. Int J Mol Med, 2008, 21:801-808.28 Chang YC, Jiang JY, Jiang YD, et al. Interaction ofADIPOQ genetic polymorphism with blood pressureand plasma cholesterol level on the risk of coronaryartery disease[J]. Stroke, 2009, 73:1934-1938.29 Cheong MY, Bang OS, Cha MH, et al. Association ofthe adiponectin gene variations with risk of ischemicstroke in a Korean population [J]. Yonsei Med J, 2011,52:20-25.30 Yang Y, Zhang F, Ding R, et al. Associat ionof ADIPOQ gene polymorphisms and coronaryartery disease risk:a meta-analysis based on 12 465subjects[J]. Thromb Res, 2012, 130:58-64. |